Related Experiment Video
Updated: Feb 7, 2026

04:29
Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits
Published on: December 13, 2024
1.3K
Migraine management in pregnancy
Clinical and Experimental Obstetrics & Gynecology
|August 4, 2018
Summary
Migraines significantly impact women, especially during hormonal changes like pregnancy. This review details evaluating and treating migraines during pregnancy and lactation, considering safety for the fetus.
Area of Science:
- Neurology
- Obstetrics & Gynecology
Background:
- Migraines affect 18% of women, often worsened by hormonal fluctuations.
- Many individuals with migraines lack proper diagnosis and treatment.
- Migraine significantly diminishes quality of life and causes missed workdays.
Purpose of the Study:
- To review the evaluation and treatment of migraines in pregnant and lactating women.
- To address the complexities of managing migraines during pregnancy due to hormonal shifts and medication risks.
- To provide guidance on safe and effective migraine management strategies for this population.
Main Methods:
- Literature review focusing on headache evaluation during pregnancy.
- Analysis of treatment options for migraines considering fetal safety.
- Synthesis of current recommendations for managing migraines in pregnant and lactating women.
Main Results:
- Hormonal fluctuations during pregnancy and lactation can alter migraine patterns.
- Increased risk of secondary headache conditions necessitates careful evaluation.
- Treatment options are limited by potential risks to the fetus and infant.
Conclusions:
- Effective management of migraines during pregnancy and lactation requires careful consideration of maternal and fetal well-being.
- Understanding the impact of hormonal changes is crucial for accurate diagnosis and treatment.
- This review offers a framework for the workup and treatment of migraines in this vulnerable population.
Related Concept Videos
Tonsillitis II: Management
438
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
438
Impression Management Techniques I: Managing Appearances
220
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
220
Managing Impressions
173
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
173
Management of Insomnia
657
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
657
Cystic Fibrosis: Management
545
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
545
Angina IV: Management
297
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
297

